We are live on ! Find out more
BCM

BlueCrest Capital Management Portfolio holdings

AUM $1.69B
1-Year Est. Return 20.01%
This Fund
S&P 500
This Quarter Est. Return
-8.58%
1 Year Est. Return
+20.01%
3 Year Est. Return
+41.66%
5 Year Est. Return
+41.11%
10 Year Est. Return
+377.48%
AUM
$1.94B
AUM Growth
-$1.81B
Cap. Flow
-$1.87B
Cap. Flow %
-96.14%
Top 10 Hldgs %
39.77%
Holding
1,768
New
295
Increased
194
Reduced
262
Closed
952

Sector Composition

Rank Sector Weight
1 Technology 32.25%
2 Financials 5.72%
3 Healthcare 4.28%
4 Consumer Discretionary 3.71%
5 Industrials 2.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTEN icon
701
Patterson-UTI
PTEN
$3.9B
$128K 0.01%
+12,389
New +$183K
SBBP
702
DELISTED
Strongbridge Biopharma plc.
SBBP
$127K 0.01%
28,435
-74,369
-72% -$363K
AGNT
703
AGNT Inc
AGNT
$693M
$126K 0.01%
35,570
+8,570
+32% +$48.1K
MGNI icon
704
Magnite
MGNI
$2.8B
$124K 0.01%
33,114
-101,962
-75% -$389K
WMC
705
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$124K 0.01%
+1,491
New +$146K
CRK icon
706
Comstock Resources
CRK
$3.94B
$121K 0.01%
+26,664
New +$196K
SRT
707
DELISTED
Startek Inc.
SRT
$121K 0.01%
18,181
+3,086
+20% +$19.2K
NG icon
708
NovaGold Resources
NG
$2.61B
$120K 0.01%
30,434
+18,414
+153% +$72.7K
GEOS icon
709
Geospace Technologies
GEOS
$97.3M
$118K 0.01%
11,440
-11,380
-50% -$152K
EGO icon
710
Eldorado Gold
EGO
$8.37B
$117K 0.01%
40,744
-55,550
-58% -$197K
KG
711
Kestrel Group
KG
$66.7M
$117K 0.01%
3,555
+918
+35% +$49.4K
OPRX icon
712
OptimizeRx
OPRX
$123M
$116K 0.01%
+10,590
New +$157K
RVPHW
713
DELISTED
Reviva Pharmaceuticals Warrants
RVPHW
$116K 0.01%
+350,000
New +$112K
WLH
714
DELISTED
WILLIAM LYON HOMES
WLH
$116K 0.01%
+10,876
New +$139K
FSM icon
715
Fortuna Silver Mines
FSM
$2.63B
$115K 0.01%
31,651
+13,162
+71% +$48.6K
ERIC icon
716
Ericsson
ERIC
$33.1B
$114K 0.01%
+12,876
New +$112K
XIN
717
DELISTED
Xinyuan Real Estate
XIN
$114K 0.01%
+2,988
New +$122K
CIG icon
718
CEMIG Preferred Shares
CIG
$6.24B
$113K 0.01%
62,242
-30,796
-33% -$46.6K
DO
719
DELISTED
Diamond Offshore Drilling
DO
$113K 0.01%
+11,925
New +$169K
ACH
720
Accendra Health
ACH
$261M
$111K 0.01%
+17,584
New +$183K
GALT icon
721
Galectin Therapeutics
GALT
$200M
$108K 0.01%
+31,614
New +$151K
YGYI
722
DELISTED
Youngevity International, Inc Common Stock
YGYI
$107K 0.01%
+18,648
New +$145K
GOGL
723
DELISTED
Golden Ocean Group
GOGL
$106K 0.01%
+17,212
New +$129K
ARQ icon
724
Arq
ARQ
$86.3M
$106K 0.01%
+10,031
New +$104K
GPOR
725
DELISTED
Gulfport Energy Corp.
GPOR
$105K 0.01%
15,969
-27,136
-63% -$251K

Similar funds

BlueCrest Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, BlueCrest Capital Management held 1,768 positions worth $1.94B, down 48% from $3.75B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

BlueCrest Capital Management withdrew a net $1.87B in Q4 2018, closing 952 positions and reducing 262 holdings. Its most notable exit was Aetna Inc, an estimated $29.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, BlueCrest Capital Management opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $39.5M.

  • BlueCrest Capital Management's largest Q4 2018 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 350,000 shares worth $39.5M.
  • BlueCrest Capital Management added most to Altaba Inc in Q4 2018, an estimated $265M increase.
  • BlueCrest Capital Management's biggest Q4 2018 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $297M.
  • BlueCrest Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $29.8M.
  • BlueCrest Capital Management's ten largest holdings make up 40% of its $1.94B portfolio in Q4 2018.
  • BlueCrest Capital Management opened 295 new positions and closed 952 in Q4 2018.
  • BlueCrest Capital Management's portfolio value fell 48% quarter-over-quarter to $1.94B.

Based on BlueCrest Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.